Charles River Laboratories International, Inc. provided financial guidance for 2024. For the period, the company expects Revenue growth to be 1.0% ? 4.0%.
organic revenue growth of 0.0% ? 3.0%, GAAP EPS estimate $7.90 ? $8.40.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
228.4 USD | +0.13% | -2.92% | -3.38% |
Charles River Laboratories International, Inc. provided financial guidance for 2024. For the period, the company expects Revenue growth to be 1.0% ? 4.0%.
organic revenue growth of 0.0% ? 3.0%, GAAP EPS estimate $7.90 ? $8.40.
1st Jan change | Capi. | |
---|---|---|
-3.38% | 11.75B | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
+20.21% | 11.72B |